Short-term impact of COVID-19 infection on right ventricular functions: single center observational study
Tóm tắt
COVID-19 pandemic is associated with high morbidity and mortality. Cardiovascular insult is a leading cause of in-hospital mortality in COVID-19 patients, especially right ventricular (RV) dysfunction and massive pulmonary embolism. This study aims to assess short-term impact of COVID 19 infection on (RV) functions among hospitalized patients with moderate or severe illness using bed side trans-thoracic echocardiogram. This study was conducted in 3 isolation hospitals in Cairo, spanning over 3 months during the expected pandemic peak in Egypt in 2020. The study recruited 100 consecutive patients with moderate or severe COVID-19 infection. Four patients refused to participate in the study. Patients with pre-existing structural heart diseases were excluded. All patients underwent full history taking and clinical examination. Bed side echocardiography was done emphasizing on (RV), and (RA) dimensions, (LV) functions and pulmonary artery systolic pressure (PSAS). Cardiac biomarkers were withdrawn and CT angiography was ordered when clinically warranted. The mean age of the studied cohort was 59.5 ± 8.6 years with males comprising 71.9% of the studied group. (RV) and (RA) dilatation was noted in 8 cases (8.3%). (LV) dysfunction was noted in 11 cases (11.4%). (PASP) showed a statistically significant negative correlation with (LV) function. However, (PSAP) was positively correlated to (RA) and (RV) dimensions, tricuspid regurgitation (TR) jet severity, previous COVID infection and elevated cardiac biomarkers. Mortality was noted in 3 cases (3.1%), all had LV dysfunction with elevated troponin level. Six patients (6.2%) had combined (LV) and (RV) dysfunction. COVID-19 illness had a negative impact on (RV) and (LV) functions, that could be assessed accurately by trans-thoracic 2 D echocardiogram. The degree of ventricular dysfunction correlated with the rise in cardiac biomarkers as well as the degree of (PASP).
Từ khóa
Tài liệu tham khảo
Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J et al (2020) COVID 19 with different severity: a multi-center study of clinical feature. Am J Respir Crit Care Med 201:1380–1381
World Health Organization (2020) Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization. https://www.who.int/emergencies/diseases/nove/coronavirus-2019/technicalguidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
Akhmerov A, Marbán E (2020) COVID-19 and the heart. Circ Res 126(10):1443–1455
Bansal M (2020) Cardiovascular disease and COVID-19. Diab Metab Syndr. https://doi.org/10.1016/j.dsx.2020.03.013
Peng Q-Y, Wang X-T, Zhang L-N (2020) Using echocardiography to guide the treatment of novel coronavirus pneumonia. Crit Care. https://doi.org/10.1186/s13054-020-02856-z
Argulian E, Sud K, Vogel B et al (2020) Right ventricular dilation in hospitalized patients with COVID-19 infection. JACC Cardio vasc Imaging 13:2459–2461
Huang L, Zhao P, Tang D et al (2020) Cardiac involvement in patients recovered from COVID-2019 identifed using magnetic resonance imaging. JACC Cardiovasc Imaging 13:2330–2339
Churchill TW, Bertrand PB, Bernard S et al (2020) Echocardiographic features of COVID-19 illness and association with cardiac biomarkers. J Am Soc Echocardiogr 33:1053–1054
Mahmoud-Elsayed HM, Moody WE, Bradlow WM et al (2020) Echocardiographic findings in patients with COVID-19 pneumonia. Can J Cardiol 36:1203–1207
Creel-Bulos C, Hockstein M, Amin N, Melhem S, Truong A, Sharifpour M (2020) Acute cor pulmonale in critically Ill patients with Covid-19. N Engl J Med 382:e70
Rauch S, Regli IB, Clara A, Seraglio PM, Bock M, Poschenrieder F, Resch M (2020) Right ventricular myopericarditis in COVID-19: a call for regular echocardiography. Minerva Anestesiol 86:1253–1254
Ferrante G, Fazzari F, Cozzi O, Maurina M, Bragato R, D’Orazio F, Torrisi C, Lanza E, Indolfi E, Donghi V et al (2020) Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography. Cardiovasc Res 116:2239–2246
Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, Kociol RD, Lewis EF, Mehra MR, Pagani FD et al (2018) Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association. Circulation 137:e578–e622
García-Cruz E, Manzur-Sandoval D, Baeza-Herrera LA, Díaz-Méndez A, López-Zamora A, González-Ruiz F, Ángel RE, Melano-Carranza E, Rojas-Velasco G, Álvarez-Álvarez RJ et al (2021) Acute right ventricular failure in COVID-19 infection: a case series. J Cardiol Cases 24:45–48
Patel BV, Arachchillage DJ, Ridge CA et al (2020) Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations. Am J Respir Crit Care Med 202:690–699
Lippi G, Lavie CJ, Sanchis-Gomar F (2020) Cardiac troponin I in patients with coronavirus disease 2019 (COVID19): evidence from a meta-analysis. Prog Cardiovasc Dis 63:390–391
Picard MH, Weiner RB (2020) Echocardiography in the time of COVID-19. J Am Soc Echocardiogr. https://doi.org/10.1016/j.echo.2020.04.011
Nagre AS (2019) Focus-assessed transthoracic echocardiography: implications in perioperative and intensive care. Ann Card Anaesth 22(3):302
Perera P, Mailhot T, Riley D, Mandavia D (2010) The RUSH exam: rapid ultrasound in shock in the evaluation of the critically lll. Emerg Med Clin 28(1):29–56
Zhang L-N, Zhang H-M, Cao Y-G, Yin W-H, He W, Zhu R et al (2017) Ten basic principles about critical ultrasonography: critical care practitioners need to know. Chin Med J 130(13):1610
Barman HA, Atici A, Tekin EA et al (2020) Echocardiographic features of patients with COVID 19 infection: a cross sectional study. Int J Cardiovasc Imaging. https://doi.org/10.1007/s10554-020-02051-9
D’Andrea A, Scarafile R, Riegler L, Liccardo B, Crescibene F, Cocchia R, Bossone E (2020) Right ventricular function and pulmonary pressures as independent predictors of survival in patients with COVID-19 pneumonia. JACC Cardiovasc Imaging 13:2467–2468
Kim J, Volodarskiy A, Sultana R, Pollie MP, Yum B, Nambiar L, Tafreshi R, Mitlak HW, RoyChoudhury A, Horn EM et al (2020) Prognostic utility of right ventricular remodeling over conventional risk stratification in patients with COVID-19. J Am Coll Cardiol 76:1965–1977
Kjaergaard J, Iversen KK, Akkan D, Møller JE, Køber LV, Torp-Pedersen C, Hassager C (2009) Predictors of right ventricular function as measured by tricuspid annular plane systolic excursion in heart failure. Cardiovasc Ultrasound 7:51
Hsiao SH, Lin SK, Wang WC, Yang SH, Gin PL, Liu CP (2006) Severe tricuspid regurgitation shows significant impact in the relationship among peak systolic tricuspid annular velocity, tricuspid annular plane systolic excursion and right ventricular ejection fraction. J Am Soc Echocardiogr 19:902–910